<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran J Pharm Res</journal-id><journal-id journal-id-type="iso-abbrev">Iran J Pharm Res</journal-id><journal-id journal-id-type="publisher-id">IJPR</journal-id><journal-title-group><journal-title>Iranian Journal of Pharmaceutical Research : IJPR</journal-title></journal-title-group><issn pub-type="ppub">1735-0328</issn><issn pub-type="epub">1726-6890</issn><publisher><publisher-name>Shaheed Beheshti University of Medical Sciences</publisher-name><publisher-loc>Tehran, Iran</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24734078</article-id><article-id pub-id-type="pmc">3985254</article-id><article-id pub-id-type="publisher-id">ijpr-13-253</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Propofol Attenuates Toxic Oxidative Stress by CCl<sub>4</sub> in Liver Mitochondria and Blood in Rat</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ranjbar</surname><given-names>Akram</given-names></name><xref ref-type="aff" rid="affa">a</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Sharifzadeh</surname><given-names>Mohammad</given-names></name><xref ref-type="aff" rid="affb">b</xref></contrib><contrib contrib-type="author"><name><surname>Karimi</surname><given-names>Jamshid</given-names></name><xref ref-type="aff" rid="affc">c</xref></contrib><contrib contrib-type="author"><name><surname>Tavilani</surname><given-names>Heidar</given-names></name><xref ref-type="aff" rid="affc">c</xref></contrib><contrib contrib-type="author"><name><surname>Baeeri</surname><given-names>Maryam</given-names></name><xref ref-type="aff" rid="affb">b</xref></contrib><contrib contrib-type="author"><name><surname>Heidary shayesteh</surname><given-names>Tavakol</given-names></name><xref ref-type="aff" rid="affa">a</xref></contrib><contrib contrib-type="author"><name><surname>Abdollahi</surname><given-names>Mohammad</given-names></name><xref ref-type="aff" rid="affb">b</xref></contrib></contrib-group><aff id="affa"><label>a</label><italic>Department of Toxicology and Pharmacology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran.</italic></aff><aff id="affb"><label>b</label><italic>Faculty of Pharmacy, and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran.</italic></aff><aff id="affc"><label>c</label><italic>Department of Biochemistry, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.</italic></aff><author-notes><corresp id="cor1"><label>*</label>Corresponding author: 
E-mail: akranjbar1389@yahoo.com
</corresp></author-notes><pub-date pub-type="ppub"><season>Winter</season><year>2014</year></pub-date><volume>13</volume><issue>1</issue><fpage>253</fpage><lpage>262</lpage><history><date date-type="received"><month>11</month><year>2012</year></date><date date-type="accepted"><month>11</month><year>2013</year></date></history><permissions><copyright-statement>&#x000a9; 2014 by School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services</copyright-statement><license><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Anti-oxidant effects of propofol (2, 6-diisopropylphenol) were evaluated agains carbon tetrachloridet CCl<sub>4</sub> -induced oxidative stress in rat liver. 30 male rats were equally divided in to 6 groups (5 rats each). Group I (control), while Group II was given CCl<sub>4</sub> (3 mL /Kg/day, IP). Animals of Groups III received only propofol (10 mg/Kg/day, IP). Group IV was given propofol+ CCl<sub>4</sub>. Group V was administered vitamin E (alpha-tocopherol acetate 15 mg/Kg/day, SC) .Animals of Group VII received alpha-tocopherol acetate + CCl<sub>4</sub> once daily for two weeks. After treatment, blood and liver mitochondria were isolated. Anti-oxidant enzymes activity such as glutathione peroxidase (GPx), superoxide dismutase (SOD) and oxidative stress marker such as reduced glutathione (GSH) and lipid peroxidation (LPO) concentration were measured. Oxidative stress induced with CCl<sub>4</sub> in liver mitochondria was evident by a significant increase in enzymatic activities of GPx, SOD, and LPO and decreased of GSH and vailability of mitochondria. Propofol and vitamin E restored CCl<sub>4</sub>-induced changes in GSH, GPx, SOD and LPO in blood and liver mitochondria. CCl<sub>4</sub> decreased viability of mitochondria that was recovered by propofol and vitamin E. It is concluded that oxidative damage is the mechanism of toxicity of CCl<sub>4</sub> in the mitochondria that can be recovered by propofol comparable to vitamin E.</p></abstract><kwd-group><title>Key Words</title><kwd>Propofol</kwd><kwd>Liver mitochondria</kwd><kwd>Oxidative stress</kwd><kwd>Rat</kwd><kwd>CCl<sub>4</sub></kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Propofol (2, 6-diisopropylphenol) is a widely used intravenous sedative-hypnotic agent for both induction/maintenance of anesthesia and sedation of critically ill patients (<xref rid="B1" ref-type="bibr">1</xref>) Advantages of this agent over others of similar applications include lower incidence of side effects (<xref rid="B2" ref-type="bibr">2</xref>) and better quality of anesthesia (<xref rid="B3" ref-type="bibr">3</xref>). Propofol's structure contains a phenolic hydroxyl group and thus resembles that of a-tocopherol (vitamin E), a natural anti-oxidant. As shown by both <italic>in-vitro</italic> and <italic>in-vivo</italic> studies, the anti-oxidant activity of propofol results partly from this phenolic chemical structure (<xref rid="B4" ref-type="bibr">4</xref>). Numerous studies have demonstrated anti-oxidant effects of propofol <italic>in-vitro</italic> (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>) and <italic>in-vivo</italic> (<xref rid="B7" ref-type="bibr">7</xref>), but actions of propofol on different cells are varied and multiple mechanisms may be involved (<xref rid="B8" ref-type="bibr">8</xref>). Propofol has been demonstrated to prevent oxidative stress-mediated endothelial cell activation and dysfunction induced by hydrogen peroxide (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B9" ref-type="bibr">9</xref>) and tumour necrosis factor-a (TNF-a) (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>). The anti-oxidant status of a cell determines its susceptibility to oxidative damage, and is usually altered in response to oxidative stress (<xref rid="B12" ref-type="bibr">12</xref>). When reactive oxygen species (ROS) generation overwhelms the anti-oxidant defense, the free radicals can interact with endogenous macromolecules and alter cellular function (<xref rid="B12" ref-type="bibr">12</xref>). The mitochondrial respiratory chain is the major source of intracellular generation of ROS and at the same time, an important target for the damaging effects of ROS (<xref rid="B13" ref-type="bibr">13</xref>).</p><p>Carbon tetrachloride (CCl<sub>4</sub>) is known to induce reactive free radicals and induction of cell damage through covalent binding to the membrane proteins (<xref rid="B14" ref-type="bibr">14</xref>).</p><p>CCl<sub>4</sub> is converted in to trichloromethyl radical (CCl<sub>3</sub>&#x02022;) and its derivative peroxy trichloromethyl radical (&#x02022;OOCCl<sub>3</sub>) by cytochrome P450 in liver microsomes. These free radicals are highly reactive and are capable of reacting with polyunsaturated fatty acids of the membranous system leading to oxidative injuries such as lipid peroxidation (<xref rid="B15" ref-type="bibr">15</xref>). The aims of this study were to investigate the anti-oxidative effects of propofol on liver mitochondrial function in rat treated with CCl<sub>4</sub><bold>.</bold></p></sec><sec><title>Experimental</title><p>
<italic>Chemicals</italic>
</p><p>Tetraethoxypropane (MDA), 2-thiobarbituric acid (TBA), trichloroace tic acid (TCA), n-butanol, propofol , sucrose, ethylenediamine tetra acetic acid (EDTA), Comassie blue, bovine serum album in (BSA), 4,5(dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), GPx and SOD (Ransel kit, Randox Laboratories Ltd, Crumlin, UK), bioxytech GSH kit (Oxis Research, USA), Comassie blue, bovine serum albumin (BSA), 4,5-(dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), were used in this study. All other chemicals were obtained from the Sigma.</p><p>
<italic>Animals and treatments</italic>
</p><p>Adult male Wistar rats weighing 180&#x02013;250 g maintained on a 12-hour light/dark cycle with free access to tap water and standard laboratory chow were used. Animals were randomly divided into six groups (n=5) and treated for 2 week intraperitoneally (IP<bold>). </bold>The groups were as follows: control group, propofol group, CCl<sub>4</sub> group, propofol and CCl<sub>4</sub> group, vitamin E group, and CCl<sub>4</sub> and vitamin E group. </p><p>Propofol was administered (10 mg/Kg/day, IP) alone or in combination with CCl<sub>4</sub> (0.2 mL/Kg /day, IP) and vitamin E as (15 mg/Kg/day, SC) One group of animals received only normal saline and was assigned as control. At the end of the treatment, 24 hours post the last dose of treatment, animals were killed, liver tissue was separated and stored in liquid nitrogen. Blood samples were collected from heart in heparinized tubes and plasma was isolated. The experiments were conducted according to the ethical rules approved by Institutional Review Board (IRB).</p><p>
<italic>Preparation of liver mitochondria</italic>
</p><p>The liver was removed and minced with small scissors in a cold manitol solution containing 0.225 M D-manitol, 75 mM sucrose, and 0.2 mM ethylenediaminetetraacetic acid (EDTA). The minced liver (30 g) was gently homogenized in a glass homogenizer with a Teflon pestle and then centrifuged at 700 &#x000d7; <italic>g </italic>for 10 min at 4 <sup>&#x025e6;</sup>C at remove nuclei, unbroken cells, and other non-subcellular tissue. The supernatants were centrifuged at 7,000 &#x000d7; <italic>g </italic>for 20 min. These second supernatants were pooled as the crude microsomal fraction and the pale loose upper layer, which was rich in swollen or broken mitochondria, lysosomes, and some microsomes, of sediments was washed away.</p><p>The dark packed lower layer (heavy mitochondrial fraction) was resuspended in the manitol solution and recentrifuged twice at 7,000&#x000d7;<italic>g </italic>for 20 min. The heavy mitochondrial sediments were suspended in Tris solution containing 0.05 M Tris-HCl buffer (pH 7.4), 0.25 M sucrose, 20 mM KCl, 2.0 mM MgCl<sub>2</sub>, and 1.0 mM Na<sub>2</sub>HPO<sub>4</sub> at 4 <sup>&#x025e6;</sup>C before assay (<xref rid="B16" ref-type="bibr">16</xref>).</p><p>
<italic>Measurement of Cu/Zn- SOD</italic>
</p><p>The activity of Cu/Zn- SOD was measured using a commercial kit (Ransod kit, Randox Laboratories Ltd, Crumlin, UK). Measurement of the enzyme was based on the generation of superoxide radicals produced by xanthine and xanthine oxidase and reacted with 2-(4-iodophenyl)-3-(4-nitrofenol) 5-phenyltetrazolium chloride (INT) to form a red formazan dye. The formazan was read at 505 nm. One unit of Cu/Zn- SOD was defined as the amount of enzyme necessary to produce 50% inhibition in the INT reduction rate. </p><p>
<italic>Measurement of GPx</italic>
</p><p>The amount of GPx was determined using a commercially available kit (Ransel kit, Randox Laboratories Ltd, Crumlin, UK) by measuring the rate of oxidation of NADPH at 340 nm. A unit of enzyme was expressed as the amount of enzyme needed to oxidize 1 nmol of NADPH oxidase/minute. </p><p>
<italic>Measurement of </italic>
<italic>reduced glutathione assay (GSH)</italic>
</p><p>Level of reduced glutathione (GSH) was measured using colorimetric assay kit. The kit uses 5, 50-dithiobis-2-nitrobenzoic acid (DTNB) and glutathione reductase. The procedure was followed according to manufacturer&#x02019;s instruction and the levels were quantitated as micromolar GSH based on standard supplied along with the kit. </p><p>
<italic>Measurement of lipid peroxidation (LPO)</italic>
</p><p>The LPO product in tissues was determined by thiobarbituric acid reagent expressed as the extent of malondialdehyde (MDA) productions during an acid heating reaction. Brie&#x0fb02;y, the samples were diluted by 1.5 mL TCA (20% w/v) was added to 250 &#x003bc;L o f this samples and centrifuged in 3000 g for 10 min. Then, the precipitation was dissolved in sulfuric acid and 1.5 mL of the mixture was added to 1.5 mL of TBA (0.2% w/v). The mixture was then incubated for 1 h in a boiling water bath. Following incubation, 2 m l of n-butanol was added, the solution centrifuged, cooled and the absorption of the supernatant was recorded in 532 nm. The calibration curve of tetraethoxypropane standard solutions was used to determine the concentrations of TBA+MDA adducts in samples (<xref rid="B17" ref-type="bibr">17</xref>). </p><p>
<italic>Total Protein</italic>
</p><p>The protein content was quanti&#x0fb01;ed by the method of Bradford. Concentrated Coomassie blue (G250) was diluted in 250 &#x003bc;L distilled water, and then 750 &#x003bc;L of this diluted dye was added to 50 &#x003bc;L of sample. The mixture was incubated at room temperature for 10 min and an absorbance measurement was taken at 595 nm by a spectrophotometer. A standard curve was constructed by using bovine serum albumin ranging between 0.25 and 1 mg/mL (<xref rid="B18" ref-type="bibr">18</xref>).</p><p>
<italic>Mitochondrial viability</italic>
</p><p>This assay is a quantitative colorimetric method to determine mitochondrial toxicity or viability of liver mitochondria. It utilizes the yellow tetrazolium salt (MTT), which is metabolized by mitochondrial dehydrogenase enzyme from viable cells to yield a purple formazan reaction product that was determined spectrophotometrically at wavelength of 570 nm. The percentage (of control) of mitochondrial viability of each test sample was calculated (<xref rid="B19" ref-type="bibr">19</xref>).</p><p>
<italic>Statistical analysis</italic>
</p><p>Mean and standard error values were determined for all the parameters and the results were expressed as Mean + SEM. All data were analyzed with SPSS Version 18 employing one-way ANOVA followed by Tukey post hoc test. Duplicate of experiments were performed. Differences between groups was considered significant when P &#x0003c; 0.05. </p></sec><sec sec-type="results"><title>Results</title><p>
<italic>Lipid peroxidation (LPO)</italic>
</p><p>In blood: CCl<sub>4</sub> caused a significant increase in LPO when compared to control (p-value &#x0003c; 0.001). Propofol caused a significant decrease in LPO when compared to CCl<sub>4</sub> group (p-value &#x0003c; 0.001). Vitamin E reduced LPO when compared to CCl<sub>4</sub> (p-value &#x0003c; 0.001). Co administration of Vitamin E with CCl<sub>4</sub> significantly reduced CCl<sub>4</sub> induced LPO (p-value &#x0003c; 0.001).</p><p>In liver mitochondria: CCl<sub>4</sub> caused a significant increase in LPO when compared to control (p-value &#x0003c; 0.001). Propofol caused a significant decrease in LPO when compared to CCl<sub>4</sub> group (p-value &#x0003c; 0.001). Vitamin E reduced LPO when compared to CCl<sub>4</sub> (p-value &#x0003c; 0.001). Coadministration of propofol or Vitamin E with CCl<sub>4</sub> significantly reduced CCl<sub>4</sub> induced LPO (p-value = 0.050 and p-value = 0.010, respectively); <xref ref-type="fig" rid="F1">Figure 1</xref>.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Lipid peroxidation (LPO) in plasma and liver mitochondria of rats. Values are the mean &#x000b1; SE (n = 5) <sup>aa</sup>Significantly different from control group at p &#x0003c; .05. <sup>bb</sup>Significantly different from CCl<sub>4</sub> group at p &#x0003c; .05. PF, Propofol; AT, (alpha-tocopherol; vitamin E). Duplicate bars from left to right represent plasma and liver mitochondria, respectively</p></caption><graphic xlink:href="ijpr-13-253-g001"/></fig><p>
<italic>Superoxide dismutase</italic>
</p><p>In blood: CCl<sub>4</sub> caused a significant increase in SOD activity when compared to control (p-value &#x0003c; 0.001). Propofol caused a significant decrease in SOD activity when compared to CCl<sub>4</sub> group (p-value &#x0003c; 0.001). Vitamin E reduced SOD activity when compared to CCl<sub>4</sub> (p-value &#x0003c; 0.001).</p><p>In liver mitochondria: Vitamin E reduced SOD activity when compared to CCl<sub>4</sub> (p-value = 0.014); <xref ref-type="fig" rid="F2">Figure 2</xref>.</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Superoxide dismutase (SOD) activity in plasma and liver mitochondria of rats. Values are the mean &#x000b1; SE (n = 5) <sup>aa</sup>Significantly different from control group at &#x0200e;p &#x0003c; .05. <sup>bb</sup>Significantly different from CCl4 group at p &#x0003c; .05. PF, Propofol; AT, (alpha-&#x0200e;tocopherol; vitamin E). Duplicate bars from left to right represent plasma and liver &#x0200e;mitochondria, respectively</p></caption><graphic xlink:href="ijpr-13-253-g002"/></fig><p>
<italic>Glutathione peroxidase</italic>
</p><p>In blood: Vitamin E reduced GPx activity when compared to CCL<sub>4</sub> (p-value = 0.004). Coadministration of propofol with Vitamin E significantly reduced CCl<sub>4</sub> induced SOD activity (p-value = 0.003 and p-value = 0.013, respectively).</p><p>In liver mitochondria: Vitamin E reduced GPx activity when compared to CCl<sub>4</sub> (p-value = 0.001); <xref ref-type="fig" rid="F3">Figure 3</xref>.</p><fig id="F3" position="float"><label>Figure 3</label><caption><p>Glutathione peroxidase (GPx) activity in plasma and liver mitochondria of rats. <sup>aa</sup>Significantly different from control group at p &#x0200e;&#x0200e;&#x0003c; .05. Values are the mean &#x000b1; SE (n = 5) <sup>bb</sup>Significantly different from CCl<sub>4</sub> group at p &#x0003c; .05. PF, Propofol; AT, (alpha-&#x0200e;tocopherol; vitamin E). Duplicate bars from left to right represent plasma and liver &#x0200e;mitochondria, respectively</p></caption><graphic xlink:href="ijpr-13-253-g003"/></fig><p>
<italic>Reduced glutathione</italic>
</p><p>In plasma: Treatment with CCl<sub>4</sub> decreased GSH as compared to control (p-value = 0.002). Propofol increased GSH as compared to CCl<sub>4</sub> group (p-value = 0.002). Vitamin E induced GSH when compared to CCl<sub>4</sub> (p-value = 0.001). </p><p>In liver mitochondria: Administration of CCl<sub>4</sub> decreased GSH in comparison to controls (p- value &#x0003c; 0.001). Treatment with propofol increased GSH as compared to CCl<sub>4</sub> group (p-value &#x0003c; 0.001). Vitamin E significantly increased GSH level as compared to CCl<sub>4</sub> group (p-value &#x0003c; 0.001). Coadministration of Vitamin E with CCl<sub>4</sub> decreased GSH in comparison to propofol (p-value &#x0003c; 0.001); <xref ref-type="fig" rid="F4">Figure 4</xref>.</p><fig id="F4" position="float"><label>Figure 4</label><caption><p>Reduced glutathione (GSH) in plasma and liver mitochondria of rats. <sup>aa</sup>Significantly different from control group at p &#x0200e;&#x0200e;&#x0003c; .05. Values are the mean &#x000b1; SE (n = 5) <sup>bb</sup>Significantly different from CCl<sub>4</sub> group at p &#x0003c; .05. PF, Propofol; AT, (alpha-&#x0200e;tocopherol; vitamin E). Duplicate bars from left to right represent plasma and liver &#x0200e;mitochondria, respectively</p></caption><graphic xlink:href="ijpr-13-253-g004"/></fig><p>
<italic>MTT cocentration</italic>
</p><p>In liver mitochondria: administration of CCl<sub>4</sub> decreased viability of cells in comparison to Vitamin E group (p-value &#x0003c; 0.001). Treatment with propofol increased viability of cells in comparison to CCl<sub>4</sub> group ( p-value &#x0003c; 0.001).Coadministration of Vitamin E and propofol with CCl<sub>4</sub> increased viability of mitochondrial cell when compared to CCL<sub>4</sub> respectively(p- value &#x0003c; 0.001, p-value = 0.002,); <xref ref-type="fig" rid="F5">Figure 5</xref>. </p><fig id="F5" position="float"><label>Figure 5</label><caption><p>Effect of propofol and CCl4 on percent (of control) mitochondrial viabilities of rat liver. <sup>aa</sup>Significantly different from control group at p &#x0003c; .05. Values are the mean &#x000b1; SE (n = 5) <sup>bb</sup>Significantly different from CCl4 group at p &#x0003c; .05. PF, Propofol; AT,(alpha- tocopherol; vitamin E).</p></caption><graphic xlink:href="ijpr-13-253-g005"/></fig></sec><sec sec-type="discussion"><title>Discussion</title><p>Overall results of the present subchronic model of toxicity confirmed potential of CCl<sub>4</sub> in induction of oxidative injuries and mitochondrial damage. Results indicated that anti-oxidant enzymes GPx, SOD and oxidative marker such as LPO are stimulated in response to exposure to CCl<sub>4</sub>, but their defense was not sufficient to overcome offending free radicals. As observed in the present results, the GSH is also reduced by CCl<sub>4</sub>. Fascinatingly, propofol indicate anti-oxidant properties as well as vitamin E were able to attenuate CCl<sub>4</sub> induced changes in almost most tested biomarkers.</p><p>In other words, CCl<sub>4</sub> induced oxidative stress by increasing free radicals like induction of cellular damage shown as increase of LPO and reduction of GSH, finally affecting anti-oxidant enzymes activities. The amelioration effect of propofol may be due to chemically similar to endogenous anti-oxidant a-tocopheral (Vitamin E) and theoretically should demonstrate similar properties (<xref rid="B20" ref-type="bibr">20</xref>). Numerous studies have demonstrated anti-oxidant effects of propofol <italic>in-vitro</italic> (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B21" ref-type="bibr">21</xref>) and <italic>in-vivo</italic> (<xref rid="B7" ref-type="bibr">7</xref>), but actions of propofol on different cells are varied and multiple mechanisms may be involved. This result indicates reduction of LPO in propofol treatment group induced by CCl<sub>4</sub>. The anti-oxidant effects of propofol may also be due to its ability to attenuate the formation of lipid peroxides (<xref rid="B22" ref-type="bibr">22</xref>), to induce the expression of anti-oxidant enzyme heme oxygenase-1 (<xref rid="B6" ref-type="bibr">6</xref>), to decrease the expression of nitric oxide synthase (NOS), (<xref rid="B23" ref-type="bibr">23</xref>) and to stabilize the mitochondrial membrane (<xref rid="B24" ref-type="bibr">24</xref>). Our findings showed that, propofol reduced oxidative biomarkers against CCl<sub>4</sub> toxicity in plasma and liver mitochondria. We determined that the propofol, mitochondrial toxicity significantly decreased, whereas it increased significantly in liver mitochondria following CCl<sub>4</sub> administration. We think it is due to anti-oxidant properties of propofol in liver mitochondria. Propofol was also shown to promote mitochondrial function by stabilizing the transmembrane electrical potential (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>) and inhibiting mitochondrial permeability transition pore opening (<xref rid="B27" ref-type="bibr">27</xref>), both contributing to suppression of mitochondrion-dependent apoptotic signaling (<xref rid="B28" ref-type="bibr">28</xref>).These findings indicate that the toxic stress of CCl<sub>4</sub> and the protective effects of propofol extensively involve mitochondrial viability (<xref ref-type="fig" rid="F5">Figure 5</xref>). The injuries induced by CCl<sub>4</sub> are resulted from free radicals through lipid peroxidation of cell membranes, reduces anti-oxidant enzyme and anti-oxidant substrates to induce oxidative stress that is an important factor in acute and chronic injuries in various tissues (<xref rid="B15" ref-type="bibr">15</xref>). The low levels of LPO in the groups receiving propofol in our study suggest that propofol prevents the lipid peroxidation caused by CCl<sub>4</sub> (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p><p>Oxidative stress may result in overproduction of oxygen free-radical precursors and/or decreased efficiency of the anti-oxidant system. CCl<sub>4</sub> and oxygen free-radical generation is associated with impaired glutathione metabolism, alterations in the anti-oxidant status (<xref rid="B29" ref-type="bibr">29</xref>). However, oxidative stress through generation of reactive oxygen species (ROS) plays an important role in producing liver damage and initiating hepatic fibrogenesis. Oxidative disruption of lipids, proteins, and DNA induces necrosis and apoptosis of hepatocytes, and amplifies the inflammatory response, resulting in initiation of fibrosis. Additionally, ROS stimulate the production of profibrogenic mediators from Kupffer cells and circulating inflammatory cells (<xref rid="B30" ref-type="bibr">30</xref>). In present study propofol inhibition of ROS formation, scavenging ROS, or interfering with ROS pathogenic signaling pathways might be the potential ways to protect mitochondrial cells from dysfunction by CCl<sub>4</sub>. While the contribution of Complex III to mitochondrial ROS production in the absence of respiratory inhibitors remains unresolved, two known effects of mitochondrial Ca<sup>+2</sup> could conceivably promote ROS production at this site. One of the key events that cause mitochondrial injury is an abnormal increase in intracellular Ca<sup>+2</sup> (<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B32" ref-type="bibr">32</xref>). It is well known that mtPT can be mediated by a concerted action between Ca<sup>2+</sup> and ROS, where ROS promote the oxidation and crosslinkage of mitochondrial membrane protein thiol groups such as GSH (<xref rid="B33" ref-type="bibr">33</xref>). The mechanisms of Ca<sup>+2</sup>-mediated mitochondrial damage involves activation of degradative enzymes, <italic>e.g.,</italic> calpain proteases and phospholipases, or enzymes that generate reactive oxygen species (ROS) capable of oxidatively modifying mitochondrial proteins and lipids (<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B35" ref-type="bibr">35</xref>). Reduced glutathione is a substrate for mitochondrial matrix glutathione peroxidase, an anti-oxidant enzyme that detoxifies H<sub>2</sub>O<sub>2</sub> and other peroxides (<xref rid="B36" ref-type="bibr">36</xref>-<xref rid="B38" ref-type="bibr">38</xref>). The results of our present investigation showed that 0.2 mL/Kg CCl<sub>4</sub> administration in rats caused significant induction in the activity of anti-oxidant enzymes and decreased GSH. GSH is a critical endogenous anti-oxidant involved in cell defense (<xref rid="B39" ref-type="bibr">39</xref>). Although GSH tends to be conserved preferentially in mitochondria, the concentration of GSH in mitochondria may be most relevant for the disposal of ROS and cell fate (<xref rid="B40" ref-type="bibr">40</xref>-<xref rid="B42" ref-type="bibr">42</xref>). The intracellular distribution of GSH, particulary interms of relative amounts of GSH and disulfide (GSSG), invarious compartments remains unclear. It is a evident, however, that GSH is present in cytosolic, mitochondrial and nuclear pools, can distribute to the nucleous under various condition and is involved in the redox regulation of signal transduction (<xref rid="B43" ref-type="bibr">43</xref>-<xref rid="B45" ref-type="bibr">45</xref>). Decrease in GSH activity during CCl<sub>4</sub> toxicity might be due to the decreased availability of GSH resulted during the enhanced oxidative damage (<xref rid="B46" ref-type="bibr">46</xref>-<xref rid="B48" ref-type="bibr">48</xref>). Improvement of blood and liver mitochondrial GSH levels in rats treated with propofol in comparison to CCl<sub>4</sub> administration further demonstrated the anti-oxidant properties of this drug (<xref ref-type="fig" rid="F4">Figure 4</xref>). This effect is established via activating the glutathione anti-oxidant system (<xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B50" ref-type="bibr">50</xref>).</p><p>ROS are produced in normal metabolic processes and are inactivated by endogenous anti-oxidant systems (<xref rid="B51" ref-type="bibr">51</xref>). The primary ROS produced by mitochondria is superoxide [89]. This highly reactive free radical is extremely short-lived (<xref rid="B52" ref-type="bibr">52</xref>-<xref rid="B54" ref-type="bibr">54</xref>) and dismutates either spontaneously or with the help of the mitochondrial superoxide dismutase forming the more ROS, H<sub>2</sub>O<sub>2</sub> (<xref rid="B55" ref-type="bibr">55</xref>, <xref rid="B56" ref-type="bibr">56</xref>). According to our opinion, the significant decrease of GPx and SOD activity in Groups Vitamin when compared to CCl<sub>4</sub> group may be explained with the suppression of physiologic ROS production by anti-oxidant agents (<xref ref-type="fig" rid="F2">Figure 2</xref>, <xref ref-type="fig" rid="F3">3</xref>).</p><p>Recently <italic>in-vitro</italic> studies showed that propofol could effectively suppress apoptotic signaling and prevent apoptotic death of myocardial cells encountering fatal stimuli (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B58" ref-type="bibr">58</xref>). In experimental hearts, propofol inhibited mitochondrial permeability transition (<xref rid="B27" ref-type="bibr">27</xref>) and ameliorated ischemia&#x02013;reperfusion injury (<xref rid="B59" ref-type="bibr">59</xref>-<xref rid="B61" ref-type="bibr">61</xref>). In fact, sustained hepatic inflammation provoked by long-term treatment with CCl<sub>4</sub> is believed to be through NF-&#x003ba;B pathway (<xref rid="B62" ref-type="bibr">62</xref>, <xref rid="B63" ref-type="bibr">63</xref>). NF-&#x003ba;B is a transcription factor consisting of p65 and p50 subunits of the Rel protein family that regulates host inflammatory and immune responses by increasing the expression of specific cellular genes (<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B65" ref-type="bibr">65</xref>). Released activated NF-&#x003ba;B complex tranlocates to the nucleus, where it regulates gene expression by binding to &#x003ba;B binding sites (<xref rid="B61" ref-type="bibr">61</xref>, <xref rid="B66" ref-type="bibr">66</xref>). </p><p>These findings support the premise that propofol can guard against the sequences of oxidative stress. Hence, the anti-oxidant properties of propofol are involved in its hepatoprotective mechanism. The powerful anti-oxidant activity of propofol has been examined previously in different oxidative stress situations (<xref rid="B67" ref-type="bibr">67</xref>). Interestingly, as evidenced by MTT assay, the present data confirm that CCl<sub>4</sub>-induced mitochondrial dysfunction can be improved by propofol. However, the exact molecular mechanisms of a putative protective role of propofol in hepatoprotection should be further investigated.</p></sec></body><back><ack><title>Acknowledgment</title><p>This study was supported by a grant from proposal numbered 90007921 at Iran National Science Foundation (INSF). </p></ack><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marik</surname><given-names>PE</given-names></name></person-group><article-title>Propofol: an immunomodulating agent Pharmacotherapy</article-title><source> J. Hum. Pharm. Drug Ther. </source><year>2005</year><volume>25</volume><fpage>28</fpage><lpage>33</lpage></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tramer</surname><given-names>M</given-names></name><name><surname>Moore</surname><given-names>A</given-names></name><name><surname>McQuay</surname><given-names>H</given-names></name></person-group><article-title>Propofol anaesthesia and postoperative nausea and vomiting: quantitative systematic review of randomized controlled studies</article-title><source> Br J. Anaes. </source><year>1997</year><volume>78</volume><fpage>247</fpage><lpage>255</lpage></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaer</surname><given-names>H</given-names></name></person-group><article-title>Propofol infusion for the maintenance of short-term anesthesia</article-title><source> Anaes</source><year>1988</year><volume>37</volume><fpage>187</fpage><lpage>192</lpage></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ansley</surname><given-names>DM</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Godin</surname><given-names>DV</given-names></name><name><surname>Garnett</surname><given-names>ME</given-names></name><name><surname>Qayumi</surname><given-names>AK</given-names></name></person-group><article-title>Propofol enhances red cell antioxidant capacity in swine and humans</article-title><source> Can J. Anest. </source><year>1998</year><volume>45</volume><fpage>233</fpage><lpage>239</lpage></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tesauro</surname><given-names>M</given-names></name><name><surname>Thompson</surname><given-names>W</given-names></name><name><surname>Moss</surname><given-names>J</given-names></name></person-group><article-title>Effect of staurosporine-induced apoptosis on endothelial nitric oxide synthase in transfected COS-7 cells and primary endothelial cells</article-title><source> Cell Death Differen</source><year>2005</year><volume>13</volume><fpage>597</fpage><lpage>606</lpage></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group><article-title>Propofol attenuation of hydrogen peroxide-mediated oxidative stress and apoptosis in cultured cardiomyocytes involves haeme oxygenase-1</article-title><source> Eur J. Anaes. </source><year>2008</year><volume>25</volume><fpage>395</fpage><lpage>402</lpage></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>K</given-names></name><name><surname>Yoshino</surname><given-names>F</given-names></name><name><surname>Takahashi</surname><given-names>SS</given-names></name><name><surname>Todoki</surname><given-names>K</given-names></name><name><surname>Maehata</surname><given-names>Y</given-names></name><name><surname>Komatsu</surname><given-names>T</given-names></name><name><surname>Yoshida</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>MC</given-names></name></person-group><article-title>Direct assessments of the anti-oxidant effects of propofol medium chain triglyceride/long chain triglyceride on the brain of stroke-prone spontaneously hypertensive rats using electron spin resonance spectroscopy</article-title><source>Anest.</source><year>2008</year><fpage>426</fpage><lpage>435</lpage></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Gu</surname><given-names>Y</given-names></name><name><surname>Shao</surname><given-names>Z</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Tan</surname><given-names>Z</given-names></name></person-group><article-title>Propofol protects against hydrogen peroxide-induced oxidative stress and cell dysfunction in human umbilical vein endothelial cells</article-title><source> Mole Cell Biochem.</source><year>2010</year><volume>339</volume><fpage>43</fpage><lpage>54</lpage></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Shravah</surname><given-names>J</given-names></name><name><surname>Luo</surname><given-names>H</given-names></name><name><surname>Raedschelders</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>DDY</given-names></name><name><surname>Ansley</surname><given-names>DM</given-names></name></person-group><article-title>Propofol protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via Akt activation and Bcl-2 up-regulation</article-title><source> Biochem Biophys. Res. Commun. </source><year>2009</year><volume>389</volume><fpage>105</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">19703415</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>T</given-names></name><name><surname>Xia</surname><given-names>Z</given-names></name></person-group><article-title>A small dose of hydrogen peroxide enhances tumor necrosis factor-alpha toxicity in inducing human vascular endothelial cell apoptosis: reversal with propofol</article-title><source> Anest Analg. </source><year>2006</year><volume>103</volume><fpage>110</fpage><lpage>116</lpage></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>Z</given-names></name><name><surname>Luo</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Irwin</surname><given-names>MG</given-names></name><name><surname>Vanhoutte</surname><given-names>PM</given-names></name></person-group><article-title>L-arginine enhances nitrative stress and exacerbates tumor necrosis factor-[alpha] toxicity to human endothelial cells in culture: prevention by propofol</article-title><source> J Cardiol. Pharm.</source><year>2010</year><volume> 55</volume><fpage>358</fpage></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdollahi</surname><given-names>M</given-names></name><name><surname>Ranjbar</surname><given-names>A</given-names></name><name><surname>Shadnia</surname><given-names>S</given-names></name><name><surname>Nikfar</surname><given-names>S</given-names></name><name><surname>Rezaie</surname><given-names>A</given-names></name></person-group><article-title>Pesticides and oxidative stress: a review</article-title><source> Med Sci. Monitor</source><year>2004</year><volume>10</volume><fpage>141</fpage></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranjbar</surname><given-names>A</given-names></name><name><surname>Ghahremani</surname><given-names>MH</given-names></name><name><surname>Sharifzadeh</surname><given-names>M</given-names></name><name><surname>Golestani</surname><given-names>A</given-names></name><name><surname>Ghazi-Khansari</surname><given-names>M</given-names></name><name><surname>Baeeri</surname><given-names>M</given-names></name><name><surname>Abdollahi</surname><given-names>M</given-names></name></person-group><article-title>Protection by pentoxifylline of malathion-induced toxic stress and mitochondrial damage in rat brain</article-title><source> Hum Experi. Toxicol.</source><year>2010</year><volume>29</volume><fpage>851</fpage><lpage>864</lpage></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soleimani</surname><given-names>H</given-names></name><name><surname>Ranjbar</surname><given-names>A</given-names></name><name><surname>Baeeri</surname><given-names>M</given-names></name><name><surname>Mohammadirad</surname><given-names>A</given-names></name><name><surname>Khorasani</surname><given-names>R</given-names></name><name><surname>Yasa</surname><given-names>N</given-names></name><name><surname>Abdollahi</surname><given-names>M</given-names></name></person-group><article-title>Rat plasma oxidation status after Nigella Sativa L. botanical treatment in CCl4-treated rats.</article-title><source> Toxicol. Mech. Meth. </source><volume>18</volume><fpage>725</fpage><lpage>731</lpage></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szymonik-Lesiuk</surname><given-names>S</given-names></name><name><surname>Czechowska</surname><given-names>G</given-names></name><name><surname>Stryjecka-Zimmer</surname><given-names>M</given-names></name><name><surname>S&#x00142;omka</surname><given-names>M</given-names></name><name><surname>Madro</surname><given-names>A</given-names></name><name><surname>Celi&#x00144;ski</surname><given-names>K</given-names></name><name><surname>Wielosz</surname><given-names>M</given-names></name></person-group><article-title>Catalase, superoxide dismutase, and glutathione peroxidase activities in various rat tissues after carbon tetrachloride intoxication</article-title><source> J Hep. Bili. Pan. Sur. </source><year>2003</year><volume>10</volume><fpage>309</fpage><lpage>315</lpage></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghazi-Khansari</surname><given-names>M</given-names></name><name><surname>Mohammadi&#x02010;Bardbori</surname><given-names>A</given-names></name><name><surname>Hosseini</surname><given-names>MJ</given-names></name></person-group><article-title>Using janus green B to study paraquat toxicity in rat liver mitochondria</article-title><source> Ann New York Acad. Sci. </source><year>2007</year><volume>1090</volume><fpage>98</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">17384251</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>K</given-names></name><name><surname>Roberts</surname><given-names>LJ</given-names></name></person-group><article-title>Measurement of lipid peroxidation</article-title><source> Free Rad Res. </source><year>1998</year><volume>28</volume><fpage>659</fpage><lpage>671</lpage></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kruger</surname><given-names>NJ</given-names></name></person-group><article-title>The Bradford method for protein quantitation</article-title><source> Methods Mol Biol. </source><year>1994</year><volume>32</volume><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">7951753</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>DML</given-names></name></person-group><article-title>Tetrazolium (MTT) assay for cellular viability and activity</article-title><source> Method Molec Biol. Clif. Totow. </source><year>1997</year><volume>79</volume><fpage>179</fpage><lpage>183</lpage></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bayona</surname><given-names>NA</given-names></name><name><surname>Gelb</surname><given-names>AW</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Wilson</surname><given-names>JX</given-names></name><name><surname>Urquhart</surname><given-names>BL</given-names></name><name><surname>Cechetto</surname><given-names>DF</given-names></name></person-group><article-title>Propofol neuroprotection in cerebral ischemia and its effects on low-molecular-weight antioxidants and skilled motor tasks</article-title><source> Anest</source><year>2004</year><volume>100</volume><fpage>1151</fpage></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Luo</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Ansley</surname><given-names>DM</given-names></name></person-group><article-title>Propofol reduces apoptosis and up-regulates endothelial nitric oxide synthase protein expression in hydrogen peroxide-stimulated human umbilical vein endothelial cells</article-title><source> Anest Analg. </source><year>2007</year><volume>105</volume><fpage>1027</fpage><lpage>1033</lpage></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahraman</surname><given-names>S</given-names></name><name><surname>Kilinc</surname><given-names>K</given-names></name><name><surname>Dal</surname><given-names>D</given-names></name><name><surname>Erdem</surname><given-names>K</given-names></name></person-group><article-title>Propofol attenuates formation of lipid peroxides in tourniquet-induced ischaemia-reperfusion injury</article-title><source> Brit J. Anaes. </source><year>1997</year><volume>78</volume><fpage>279</fpage><lpage>281</lpage></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goode</surname><given-names>HF</given-names></name><name><surname>Cowley</surname><given-names>HC</given-names></name><name><surname>Walker</surname><given-names>BE</given-names></name><name><surname>Howdle</surname><given-names>PD</given-names></name><name><surname>Webster</surname><given-names>NR</given-names></name></person-group><article-title>Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction</article-title><source> Crit Care Med. </source><year>1995</year><volume>23</volume><fpage>646</fpage><lpage>651</lpage><pub-id pub-id-type="pmid">7712754</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eriksson</surname><given-names>O</given-names></name></person-group><article-title>Effects of the general anaesthetic Propofol on the Ca2+-induced permeabilization of rat liver mitochondria</article-title><source> FEBS Lett</source><year>1991</year><volume> 279</volume><fpage>45</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">1704857</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Branca</surname><given-names>D</given-names></name><name><surname>Roberti</surname><given-names>MS</given-names></name><name><surname>Lorenzin</surname><given-names>P</given-names></name><name><surname>Vincenti</surname><given-names>E</given-names></name><name><surname>Scutari</surname><given-names>G</given-names></name></person-group><article-title>Influence of the anesthetic 2, 6-diisopropylphenol on the oxidative phosphorylation of isolated rat liver mitochondria</article-title><source> Biochem Pharm.</source><year>1991</year><volume>42</volume><fpage>87</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">2069600</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsujimoto</surname><given-names>Y</given-names></name><name><surname>Shimizu</surname><given-names>S</given-names></name></person-group><article-title>Role of the mitochondrial membrane permeability transition in cell death</article-title><source> Apop</source><year>2007</year><volume> 12</volume><fpage>835</fpage><lpage>840</lpage></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javadov</surname><given-names>SA</given-names></name><name><surname>Lim</surname><given-names>KHH</given-names></name><name><surname>Kerr</surname><given-names>PM</given-names></name><name><surname>Suleiman</surname><given-names>MS</given-names></name><name><surname>Angelini</surname><given-names>GD</given-names></name><name><surname>Halestrap</surname><given-names>AP</given-names></name></person-group><article-title>Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition</article-title><source> Card Res </source><year>2000</year><volume>45</volume><fpage>360</fpage><lpage>369</lpage></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crompton</surname><given-names>M</given-names></name></person-group><article-title>The mitochondrial permeability transition pore and its role in cell death</article-title><source> Biochem J. </source><year>1999</year><volume>341</volume><fpage>233</fpage><pub-id pub-id-type="pmid">10393078</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>MT</given-names></name><name><surname>Haselkorn</surname><given-names>T</given-names></name><name><surname>Bunce</surname><given-names>M</given-names></name><name><surname>Sanchez</surname><given-names>JJ</given-names></name><name><surname>Lucas</surname><given-names>SB</given-names></name><name><surname>Jewell</surname><given-names>LD</given-names></name><name><surname>Van</surname><given-names>Marck E</given-names></name><name><surname>Worobey</surname><given-names>M</given-names></name></person-group><article-title>The isolation of nucleic acids from fixed, paraffin-embedded tissues&#x02013;which methods are useful when? </article-title><source>PLoS One</source><year>2007</year><volume>2</volume><fpage>537</fpage></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>SL</given-names></name></person-group><article-title>Mechanisms of hepatic fibrogenesis</article-title><source> Gastro</source><year>2008</year><volume>134</volume><fpage>1655</fpage><lpage>1669</lpage></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schild</surname><given-names>L</given-names></name><name><surname>Huppelsberg</surname><given-names>J</given-names></name><name><surname>Kahlert</surname><given-names>S</given-names></name><name><surname>Keilhoff</surname><given-names>G</given-names></name><name><surname>Reiser</surname><given-names>G</given-names></name></person-group><article-title>Brain mitochondria are primed by moderate Ca2+ rise upon hypoxia/reoxygenation for functional breakdown and morphological disintegration</article-title><source> J Biol. Chem. </source><year>2003</year><volume>278</volume><fpage>25454</fpage><lpage>25460</lpage><pub-id pub-id-type="pmid">12702720</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abo-Hashema</surname><given-names>KAH</given-names></name><name><surname>Cake</surname><given-names>MH</given-names></name><name><surname>Potter</surname><given-names>IC</given-names></name></person-group><article-title>Liver mitochondria, confirmed as intact by complete suppression of succinate uptake and oxidation, possess a carnitine palmitoyltransferase I that is totally inhibited by malonyl CoA</article-title><source> Biochem Biophys. Res. Commun.</source><year>1999</year><volume>258</volume><fpage>778</fpage><lpage>783</lpage><pub-id pub-id-type="pmid">10329463</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maciel</surname><given-names>EN</given-names></name><name><surname>Vercesi</surname><given-names>AE</given-names></name><name><surname>Castilho</surname><given-names>RF</given-names></name></person-group><article-title>Oxidative stress in Ca2+&#x02010;induced membrane permeability transition in brain mitochondria</article-title><source> J Neurochem. </source><year>2002</year><volume>79</volume><fpage>1237</fpage><lpage>1245</lpage><pub-id pub-id-type="pmid">11752064</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Starkov</surname><given-names>AA</given-names></name><name><surname>Chinopoulos</surname><given-names>C</given-names></name><name><surname>Fiskum</surname><given-names>G</given-names></name></person-group><article-title>Mitochondrial calcium and oxidative stress as mediators of ischemic brain injury</article-title><source> Cell Cal</source><year>2004</year><volume>36</volume><fpage>257</fpage><lpage>264</lpage></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borutaite</surname><given-names>V</given-names></name></person-group><article-title>Mitochondria as decision&#x02010;makers in cell death</article-title><source> Environm Mol. Mut. </source><year>2010</year><volume>51</volume><fpage>406</fpage><lpage>416</lpage></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreyev</surname><given-names>AY</given-names></name><name><surname>Kushnareva</surname><given-names>YE</given-names></name><name><surname>Starkov</surname><given-names>A</given-names></name></person-group><article-title>Mitochondrial metabolism of reactive oxygen species</article-title><source> Biochem</source><year>2005</year><volume>70</volume><fpage>200</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">15807660</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mar&#x000ed;</surname><given-names>M</given-names></name><name><surname>Morales</surname><given-names>A</given-names></name><name><surname>Colell</surname><given-names>A</given-names></name><name><surname>Garc&#x000ed;a-Ruiz</surname><given-names>C</given-names></name><name><surname>Fern&#x000e1;ndez-Checa</surname><given-names>JC</given-names></name></person-group><article-title>Mitochondrial glutathione, a key survival antioxidant</article-title><source> Antioxid Redox. Signal. </source><year>2009</year><volume>11</volume><fpage>2685</fpage><lpage>2700</lpage><pub-id pub-id-type="pmid">19558212</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shlafer</surname><given-names>M</given-names></name><name><surname>Myers</surname><given-names>CL</given-names></name><name><surname>Adkins</surname><given-names>S</given-names></name></person-group><article-title>Mitochondrial hydrogen peroxide generation and activities of glutathione peroxidase and superoxide dismutase following global ischemia</article-title><source> J Mol. Cell Card.</source><year>1987</year><volume> 19</volume><fpage>1195</fpage><lpage>206</lpage></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez&#x02010;Checa</surname><given-names>J</given-names></name><name><surname>Garc&#x000ed;a&#x02010;Ruiz</surname><given-names>C</given-names></name><name><surname>Colell</surname><given-names>A</given-names></name><name><surname>Morales</surname><given-names>A</given-names></name><name><surname>Mar&#x000ed;</surname><given-names>M</given-names></name><name><surname>Miranda</surname><given-names>M</given-names></name><name><surname>Ardite</surname><given-names>E</given-names></name></person-group><article-title>Oxidative stress: role of mitochondria and protection by glutathione</article-title><source> Biof</source><year>2008</year><volume>8</volume><fpage>7</fpage><lpage>11</lpage></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Griffith</surname><given-names>OW</given-names></name><name><surname>Meister</surname><given-names>A</given-names></name></person-group><article-title>Origin and turnover of mitochondrial glutathione</article-title><source>Proceed. Nat. Acad. Sci. </source><year>1985</year><volume>82</volume><publisher-loc>USA</publisher-loc><fpage>4668</fpage></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurosawa</surname><given-names>K</given-names></name><name><surname>Hayashi</surname><given-names>N</given-names></name><name><surname>Sato</surname><given-names>N</given-names></name><name><surname>Kamada</surname><given-names>T</given-names></name><name><surname>Tagawa</surname><given-names>K</given-names></name></person-group><article-title>Transport of glutathione across the mitochondrial membranes</article-title><source> Biochem Biophy. Res. Commun. </source><year>1990</year><volume>167</volume><fpage>367</fpage><lpage>372</lpage></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von</surname><given-names>Montfort C</given-names></name><name><surname>Matias</surname><given-names>N</given-names></name><name><surname>Fernandez</surname><given-names>A</given-names></name><name><surname>Fucho</surname><given-names>R</given-names></name><name><surname>Conde</surname><given-names>de la Rosa L</given-names></name><name><surname>Martinez-Chantar</surname><given-names>ML</given-names></name><name><surname>Mato</surname><given-names>JM</given-names></name><name><surname>Machida</surname><given-names>K</given-names></name><name><surname>Tsukamoto</surname><given-names>H</given-names></name><name><surname>Murphy</surname><given-names>MP</given-names></name><name><surname>Mansouri</surname><given-names>A</given-names></name><name><surname>Kaplowitz</surname><given-names>N</given-names></name><name><surname>Garcia-Ruiz</surname><given-names>C</given-names></name><name><surname>Fernandez-Checa</surname><given-names>JC</given-names></name></person-group><article-title>Mitochondrial GSH determines the toxic or therapeutic potential of superoxide scavenging in steatohepatitis</article-title><source> J Hep. </source><year>2012</year><volume>57</volume><fpage>852</fpage><lpage>859</lpage></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voehringer</surname><given-names>D</given-names></name><name><surname>McConkey</surname><given-names>D</given-names></name><name><surname>McDonnell</surname><given-names>T</given-names></name><name><surname>Brisbay</surname><given-names>S</given-names></name><name><surname>Meyn</surname><given-names>R</given-names></name></person-group><article-title>Bcl-2 expression causes redistribution of glutathione to the nucleus</article-title><source> Proceed Nat. Aca. Sci.</source><year>1998</year><volume> 95</volume><fpage>2956</fpage><lpage>2960</lpage></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Briviba</surname><given-names>K</given-names></name><name><surname>Fraser</surname><given-names>G</given-names></name><name><surname>Sies</surname><given-names>H</given-names></name><name><surname>Ketterer</surname><given-names>B</given-names></name></person-group><article-title>Distribution of the monochlorobimane-glutathione conjugate between nucleus and cytosol in isolated hepatocytes</article-title><source> Biochem J. </source><year>1993</year><volume>294</volume><fpage>631</fpage><pub-id pub-id-type="pmid">8379916</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunes</surname><given-names>C</given-names></name><name><surname>Barbosa</surname><given-names>RM</given-names></name><name><surname>Almeida</surname><given-names>L</given-names></name><name><surname>Laranjinha</surname><given-names>J</given-names></name></person-group><article-title>Nitric oxide and DOPAC-induced cell death: from GSH depletion to mitochondrial energy crisis</article-title><source> Mol Cell. Neurosci. </source><year>2011</year><volume> 48</volume><fpage>94</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">21708261</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>RA</given-names></name><name><surname>Khan</surname><given-names>MR</given-names></name><name><surname>Ahmed</surname><given-names>M</given-names></name><name><surname>Sahreen</surname><given-names>S</given-names></name><name><surname>Shah</surname><given-names>NA</given-names></name><name><surname>Shah</surname><given-names>MS</given-names></name><name><surname>Bokhari</surname><given-names>J</given-names></name><name><surname>Rashid</surname><given-names>U</given-names></name><name><surname>Ahmad</surname><given-names>B</given-names></name><name><surname>Jan</surname><given-names>S</given-names></name></person-group><article-title>Hepatoprotection with a chloroform extract of Launaea procumbens against CCl4-induced injuries in rats</article-title><source> BMC Complem Alter. Med. </source><year>2012</year><volume>12</volume><fpage>114</fpage></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mujeeb</surname><given-names>M</given-names></name><name><surname>Khan</surname><given-names>SA</given-names></name><name><surname>Aeri</surname><given-names>V</given-names></name><name><surname>Ali</surname><given-names>B</given-names></name></person-group><article-title> Hepatoprotective Activity of the Ethanolic Extract &#x0200e;of Ficus carica Linn. Leaves in Carbon Tetrachloride-Induced Hepatotoxicity in Rats</article-title><source>&#x0200e;Iran. J. Pharma. Sci</source><year>2011</year><volume>10</volume><fpage>301</fpage><lpage>306</lpage></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balbis</surname><given-names>E</given-names></name><name><surname>Patriarca</surname><given-names>S</given-names></name><name><surname>Furfaro</surname><given-names>AL</given-names></name><name><surname>Millanta</surname><given-names>S</given-names></name><name><surname>Sukkar</surname><given-names>SG</given-names></name><name><surname>Marinari</surname><given-names>UM</given-names></name><name><surname>Pronzato</surname><given-names>MA</given-names></name><name><surname>Cottalasso</surname><given-names>D</given-names></name><name><surname>Traverso</surname><given-names>N</given-names></name></person-group><article-title>Whey proteins influence hepatic glutathione after CCl4 intoxication</article-title><source> Toxicol Indus. Health. </source><year>2009</year><volume>25</volume><fpage>325</fpage><lpage>328</lpage></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De</surname><given-names>La Cruz J</given-names></name><name><surname>Zanca</surname><given-names>A</given-names></name><name><surname>Carmona</surname><given-names>J</given-names></name><name><surname>de</surname><given-names>la Cuesta FS</given-names></name></person-group><article-title>The effect of propofol on oxidative stress in platelets from surgical patients</article-title><source> Anest Analg. </source><year>1999</year><volume>89</volume><fpage>1050</fpage></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozt&#x000fc;rk</surname><given-names>E</given-names></name><name><surname>Demirbilek</surname><given-names>S</given-names></name><name><surname>K&#x000f6;ro&#x0011f;lu</surname><given-names>A</given-names></name><name><surname>But</surname><given-names>A</given-names></name><name><surname>Bege&#x000e7;</surname><given-names>ZO</given-names></name><name><surname>G&#x000fc;lec</surname><given-names>M</given-names></name><name><surname>Akyol</surname><given-names>O</given-names></name><name><surname>Ersoy</surname><given-names>MO</given-names></name></person-group><article-title>Propofol and erythropoietin antioxidant properties in rat brain injured tissue</article-title><source> Prog Neuro-Psychopharm. Biol. Psych. </source><year>2008</year><volume>32</volume><fpage>81</fpage><lpage>86</lpage></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halliwell</surname><given-names>B</given-names></name></person-group><article-title>Free radicals and antioxidants: a personal view</article-title><source> Nut Rev. </source><year>1994</year><volume>52</volume><fpage>253</fpage><lpage>565</lpage></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dionisi</surname><given-names>O</given-names></name><name><surname>Galeotti</surname><given-names>T</given-names></name><name><surname>Terranova</surname><given-names>T</given-names></name><name><surname>Azzi</surname><given-names>A</given-names></name></person-group><article-title>Superoxide radicals and hydrogen peroxide formation in mitochondria from normal and neoplastic tissues</article-title><source> Biochim Biophys. Acta </source><year>1975</year><volume>403</volume><fpage>292</fpage><pub-id pub-id-type="pmid">241399</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buettner</surname><given-names>GR</given-names></name></person-group><article-title>Superoxide dismutase in redox biology: the roles of superoxide and hydrogen peroxide</article-title><source> Anti-can Age Med. Chem. </source><year>2011</year><volume>11</volume><fpage>341</fpage></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>CA</given-names></name></person-group><article-title>Generation of Superoxide Anion by Succinate-Cytochromec Reductase from Bovine Heart Mitochondria</article-title><source> J Biol. Chem. </source><year>1998</year><volume>273</volume><fpage>33972</fpage><lpage>33976</lpage><pub-id pub-id-type="pmid">9852050</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>MP</given-names></name></person-group><article-title>How mitochondria produce reactive oxygen species</article-title><source> Biochem J.</source><year>2009</year><volume> 417</volume><fpage>1</fpage><pub-id pub-id-type="pmid">19061483</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawyer</surname><given-names>DT</given-names></name><name><surname>Valentine</surname><given-names>JS</given-names></name></person-group><article-title>How super is superoxide? Acco</article-title><source> Chem Res. </source><year>1981</year><volume>14</volume><fpage>393</fpage><lpage>400</lpage></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Chang</surname><given-names>WC</given-names></name><name><surname>Hwang</surname><given-names>KC</given-names></name><name><surname>Choi</surname><given-names>IG</given-names></name><name><surname>Park</surname><given-names>WK</given-names></name></person-group><article-title>Effect of propofol on calcium homeostasis in hypoxia-reoxygenated neonatal rat cardiomyocytes</article-title><source> Eur J. Pharm. </source><year>2008</year><volume>594</volume><fpage>139</fpage><lpage>145</lpage></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noh</surname><given-names>HS</given-names></name><name><surname>Shin</surname><given-names>IW</given-names></name><name><surname>Ha</surname><given-names>JH</given-names></name><name><surname>Hah</surname><given-names>YS</given-names></name><name><surname>Baek</surname><given-names>SM</given-names></name><name><surname>Kim</surname><given-names>DR</given-names></name></person-group><article-title>Propofol protects the autophagic cell death induced by the ischemia/reperfusion injury in rats</article-title><source> Mol Cells. </source><year>2010</year><volume>30</volume><fpage>455</fpage><lpage>460</lpage><pub-id pub-id-type="pmid">20821058</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dehkordi</surname><given-names>ME</given-names></name><name><surname>Razavi</surname><given-names>SS</given-names></name><name><surname>Momenzadeh</surname><given-names>S</given-names></name></person-group><article-title>A Comparison between Sedative Effect of &#x0200e;Propofol-Fentanyl and Propofol-Midazolam Combinations in Microlaryngeal Surgeries</article-title><source> &#x0200e;Iran J. Pharma. Sci. </source><year>2012</year><volume>11</volume><fpage>287</fpage><lpage>94</lpage></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Tang</surname><given-names>Q</given-names></name><name><surname>Zou</surname><given-names>H</given-names></name></person-group><article-title>Comparison of the effects of propofol and midazolam on inflammation and oxidase stress in children with congenital heart disease undergoing cardiac surgery</article-title><source> Yon Med. J. </source><year>2011</year><volume> 52</volume><fpage>326</fpage><lpage>332</lpage></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>HC</given-names></name><name><surname>Yeh</surname><given-names>YC</given-names></name><name><surname>Wang</surname><given-names>LC</given-names></name><name><surname>Ting</surname><given-names>CT</given-names></name><name><surname>Lee</surname><given-names>WL</given-names></name><name><surname>Lee</surname><given-names>HW</given-names></name><name><surname>Wang</surname><given-names>KY</given-names></name><name><surname>Wu</surname><given-names>A</given-names></name><name><surname>Su</surname><given-names>CS</given-names></name><name><surname>Liu</surname><given-names>TJ</given-names></name></person-group><article-title>Propofol ameliorates doxorubicin-induced oxidative stress and cellular apoptosis in rat cardiomyocytes</article-title><source> Toxicol App. Pharm</source><year>2011</year><volume> 257</volume><fpage>437</fpage><lpage>448</lpage></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orfila</surname><given-names>C</given-names></name><name><surname>Lepert</surname><given-names>JC</given-names></name><name><surname>Alric</surname><given-names>L</given-names></name><name><surname>Carrera</surname><given-names>G</given-names></name><name><surname>B&#x000e9;raud</surname><given-names>M</given-names></name><name><surname>Pipy</surname><given-names>B</given-names></name></person-group><article-title>Immunohistochemical distribution of activated nuclear factor &#x003ba;B and peroxisome proliferator-activated receptors in carbon tetrachloride-induced chronic liver injury in rats</article-title><source> Histochem Cell Bio. </source><year>2005</year><volume>123</volume><fpage>585</fpage><lpage>593</lpage><pub-id pub-id-type="pmid">15959796</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Son</surname><given-names>G</given-names></name><name><surname>Iimuro</surname><given-names>Y</given-names></name><name><surname>Seki</surname><given-names>E</given-names></name><name><surname>Hirano</surname><given-names>T</given-names></name><name><surname>Kaneda</surname><given-names>Y</given-names></name><name><surname>Fujimoto</surname><given-names>J</given-names></name></person-group><article-title>Selective inactivation of NF-&#x003ba;B in the liver using NF-&#x003ba;B decoy suppresses CCl4-induced liver injury and fibrosis</article-title><source> Am J. Physiol. Gastro. Liver Physiol. </source><year>2007</year><volume>293</volume><fpage>631</fpage><lpage>639</lpage></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>S</given-names></name><name><surname>Mann</surname><given-names>DA</given-names></name></person-group><article-title>Signal transduction via the NF&#x02010;&#x003ba;B pathway: a targeted treatment modality for infection, inflammation and repair</article-title><source> Cell Biochem Func. </source><year>2004</year><volume>22</volume><fpage>67</fpage><lpage>79</lpage></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamdy</surname><given-names>N</given-names></name><name><surname>El-Demerdash</surname><given-names>E</given-names></name></person-group><article-title>New therapeutic aspect for carvedilol: Antifibrotic effects of carvedilol in chronic carbon tetrachloride-induced liver damage</article-title><source> Toxicol Appl. Pharm. </source><year>2012</year><volume>261</volume><fpage>292</fpage><lpage>299</lpage></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayden</surname><given-names>M</given-names></name><name><surname>West</surname><given-names>A</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name></person-group><article-title>NF-&#x003ba;B and the immune response</article-title><source> Oncogene</source><year>2006</year><volume>25</volume><fpage>6758</fpage><lpage>6780</lpage><pub-id pub-id-type="pmid">17072327</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostopanagiotou</surname><given-names>GG</given-names></name><name><surname>Grypioti</surname><given-names>AD</given-names></name><name><surname>Matsota</surname><given-names>P</given-names></name><name><surname>Mykoniatis</surname><given-names>MG</given-names></name><name><surname>Demopoulos</surname><given-names>CA</given-names></name><name><surname>Papadopoulou-Daifoti</surname><given-names>Z</given-names></name><name><surname>Pandazi</surname><given-names>A</given-names></name></person-group><article-title>Acetaminophen-induced liver injury and oxidative stress: protective effect of propofol</article-title><source> Eur J. Anaest.</source><year>2009</year><volume>26</volume><fpage>548</fpage><lpage>553</lpage></element-citation></ref></ref-list></back></article>